Investor profile
Debiopharm Innovation Fund has backed 5 European tech companies across 5 funding rounds between 2020 and 2023, joining rounds totalling €51M. Most active in Healthtech and AI. Data as of 7 Aug 2026.
Hover a node for shared-deal counts; click a co-investor to open its profile.
Best viewed on a larger screen.
| Company | Country | Rounds | Total € |
|---|---|---|---|
| Iktos | France | 1 | €16M |
| Oncomfort | Belgium | 1 | €10M |
| Fosanis | Germany | 1 | €10M |
| Whitelab Genomics | France | 1 | €9.8M |
| Nucleai | Israel |
| 1 |
| €5.8M |
| €9.8M |
| 2022-09 |
| Nucleai | Series A | €5.8M | 2020-07 |
